Evotec SE (OTCMKTS:EVTCY – Get Free Report) hit a new 52-week low on Wednesday . The stock traded as low as $5.14 and last traded at $5.19, with a volume of 41814 shares. The stock had previously closed at $5.14.
Evotec Trading Up 1.0 %
The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The stock has a market capitalization of $1.71 billion, a PE ratio of 12.54 and a beta of 0.98. The business’s 50-day moving average is $6.98 and its two-hundred day moving average is $8.44.
Evotec Company Profile
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Stories
- Five stocks we like better than Evotec
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- 3 Warren Buffett Stocks to Buy Now
- Generac Powers Ahead on the Electrification Mega-Trend
- How to Read Stock Charts for Beginners
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
